Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 0904-6570

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 0904-6570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C7ad16c7 Ae48 4ab1 Bebb 19897aa80159 00

This is a product label for Oxybutynin Chloride Extended-Release tablets, with the National Drug Code (NDC) 0904-6570-61. The tablets are available in unit doses, and are only available by prescription. The label provides information on dosage, dosage form, and other important details for the medication.*

FDA Label Image

Structural Formula (Oxybutynin Chloride Extended Release Tablets Usp 1)

FDA Label Image

Figure 1 (Oxybutynin Chloride Extended Release Tablets Usp 2)

This text appears to be a medical prescription for two different doses of oxybutynin chloride, a medication commonly used to treat overactive bladder. The prescription suggests taking 10mg of oxybutynin chloride once a day and 5mg three times a day. The rest of the text is not useful and contains errors.*

FDA Label Image

Figure 2 (Oxybutynin Chloride Extended Release Tablets Usp 3)

FDA Label Image

Study 1 (Oxybutynin Chloride Extended Release Tablets Usp 4)

FDA Label Image

Study 2 (Oxybutynin Chloride Extended Release Tablets Usp 5)

FDA Label Image

Study 3 (Oxybutynin Chloride Extended Release Tablets Usp 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.